Authors
Wisam Sbeit, Moaad Farraj, Tawfik Khoury
Published in
Cytopathology : official journal of the British Society for Clinical Cytology. Jun 19, 2026. Epub Jun 19, 2026.
Abstract
Endoscopic ultrasound guided fine needle aspiration/biopsy (EUS-FNA/FNB) is the main diagnostic tool for solid pancreatic lesions. However, it is associated with a limited diagnostic yield.
We aimed to assess the optimal needle passes number of FNA\FNB needles to achieve maximum diagnostic yield.
We performed a retrospective study including all patients who were diagnosed with pancreatic adenocarcinoma by EUS-FNA/FNB. The diagnostic yield was reported for all needles according to the number of needle passes.
Overall, 227 patients underwent EUS-FNA/FNB. FNBs in 85 patients (37.4%), and FNA in 142 patients (62.5%). The needle number passes in the FNB was 1.46 ± 0.70 versus 2.11 ± 1.12 in the FNA group (p < 0.0001). One, two, and three needle passes yielded a diagnosis rate of malignancy in 76.8%, 68.4% and 70% of cases respectively for histology, while for cytology, the yield was 78.6%, 89.4% and 100%, respectively. For FNB needle types, the acquire needle outperformed the other needle, as the histological yield for one pass was 78.6%, 80% for two passes, and 57.1% for three passes, while for cytology, the yield was 79.3%, 90%, and 100% for one, two and three passes, respectively. For the FNA needle, the cytological yield was 88.7% for one pass, and higher for two and three passes.
The number of needle passes for FNB (maximum three passes) was lower than FNA needles (3-4 passes) to obtain an optimal diagnostic yield.
PMID:
42322014
Bibliographic data and abstract were imported from PubMed on 20 Jun 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 1
- Comments 0